AND [H]OC1(C2=C([H])C([H])=C(Cl)C([H])=C2[H])C([H])([H])C([H])([H])NC([H])([H])C1([H])[H] Mrv1718010261720062D 0 0 0 0 0 999 V3000 M V30 BEGIN CTAB M V30 COUNTS 22 22 0 0 0 M V30 BEGIN ATOM M V30 1 H -8.0021 4.62 0 0 M V30 2 C -6.6684 3.85 0 0 M V30 3 C -5.3347 4.62 0 0 M V30 4 H -5.3347 6.16 0 0 M V30 5 C -4.001 3.85 0 0 M V30 6 C -4.001 2.31 0 0 M V30 7 H -2.6674 1.54 0 0 M V30 8 C -5.3347 1.54 0 0 M V30 9 H -5.3347 0 0 0 M V30 10 C -6.6684 2.31 0 0 M V30 11 F -8.0021 1.54 0 0 M V30 12 C -2.6674 4.62 0 0 M V30 13 O -2.6674 6.16 0 0 M V30 14 C -1.3337 3.85 0 0 M V30 15 H -2.0248 2.4738 0 0 M V30 16 H -0.6425 2.4738 0 0 M V30 17 C 0 4.62 0 0 M V30 18 H 0.6912 5.9962 0 0 M V30 19 H -0.6912 5.9962 0 0 M V30 20 C 1.3337 3.85 0 0 M V30 21 O 2.6674 4.62 0 0 M V30 22 O 1.3337 2.31 0 0 M V30 END ATOM M V30 BEGIN BOND M V30 1 1 1 2 M V30 2 2 2 3 M V30 3 1 3 4 M V30 4 1 3 5 M V30 5 2 5 6 M V30 6 1 6 7 M V30 7 1 6 8 M V30 8 1 8 9 M V30 9 2 8 10 M V30 10 1 2 10 M V30 11 1 10 11 M V30 12 1 5 12 M V30 13 2 12 13 M V30 14 1 12 14 M V30 15 1 14 15 M V30 16 1 14 16 M V30 17 1 14 17 M V30 18 1 17 18 M V30 19 1 17 19 M V30 20 1 17 20 M V30 21 1 20 21 M V30 22 2 20 22 M V30 END BOND M V30 END CTAB M END > DBMET01676 > drugbank > [H]C1=C([H])C(=C([H])C([H])=C1F)C(=O)C([H])([H])C([H])([H])C(O)=O > InChI=1S/C10H9FO3/c11-8-3-1-7(2-4-8)9(12)5-6-10(13)14/h1-4H,5-6H2,(H,13,14) > WUYWHIAAQYQKPP-UHFFFAOYSA-N > C10H9FO3 > 196.177 > 196.053572313 > 3 > 23 > 18.349189176330533 > 1 > 1 > 0 > 1 > 4-(4-fluorophenyl)-4-oxobutanoic acid > 1.46 > 1.4984580179999998 > -2.28 > 0 > 1 > -1 > 16.903449961272074 > 3.6683570574274054 > -7.445833134102566 > 54.37 > 47.5705 > 4 > 1 > 1.02e+00 g/l > 4-(4-fluorophenyl)-4-oxobutanoic acid > 0 > DBMET01676 > p-Fluorobenzoylpropionic acid and 4-(4-chlorophenyl)-4-hydroxypiperidine > V2Z6N6JC9Z $$$$